Xiaoxu Liu Selected Research

Xiaoxu Liu Research Topics

Disease

11	Neoplasms (Cancer) 10/2023 - 09/2008
5	Breast Neoplasms (Breast Cancer) 04/2022 - 03/2008
3	Pain (Aches) 01/2024 - 01/2022
3	Neoplasm Metastasis (Metastasis) 04/2022 - 09/2016
2	Esophageal Squamous Cell Carcinoma 01/2023 - 04/2020
2	Urinary Incontinence 01/2022 - 01/2018
2	Carcinogenesis 11/2021 - 04/2020
2	Infections 11/2019 - 06/2013
1	Fatigue 01/2024
1	Endometriosis 11/2023
1	Pre-Eclampsia (Preeclampsia) 05/2023
1	Tinnitus 01/2023
1	Neuroblastoma 01/2023
1	Hypothermia 01/2023
1	Postoperative Pain 12/2022
1	Rupture 08/2022
1	Tracheal Stenosis 08/2022
1	Pathologic Constriction (Stenosis) 08/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Opioid-Induced Constipation 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Pelvic Organ Prolapse 01/2022
1	Ovarian Epithelial Carcinoma 01/2022
1	Adenocarcinoma of Lung 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Bacterial Infections (Bacterial Infection) 11/2019
1	Hypoxia (Hypoxemia) 10/2018
1	Nocturia 01/2018
1	Transverse Myelitis (Necrotizing Myelitis) 01/2018
1	Urinary Retention 12/2017
1	Spinal Stenosis (Stenosis, Spinal) 11/2016
1	Colorectal Neoplasms (Colorectal Cancer) 09/2016
1	Stress Urinary Incontinence 01/2016
1	Chronic Urticaria 09/2015
1	Necrosis 09/2015
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2015
1	Hyperthermia 03/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2013
1	Cocaine-Related Disorders (Cocaine Addiction) 10/2011

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	Long Noncoding RNAIBA 04/2020 - 10/2018
2	HydrogelsIBA 01/2024 - 12/2022
2	LipidsIBA 12/2022 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2022 - 10/2018
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 11/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 09/2015
1	Photosensitizing Agents (Photosensitizers)IBA 10/2023
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2023
1	CytokinesIBA 05/2023
1	Immunologic Factors (Immunomodulators)IBA 05/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Local AnestheticsIBA 12/2022
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 12/2022
1	ChitosanIBA 12/2022
1	NanocapsulesIBA 12/2022
1	caprolactoneIBA 12/2022
1	genipinIBA 12/2022
1	Therapeutic UsesIBA 08/2022
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2022
1	ForminsIBA 04/2022
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 04/2022
1	Actin Depolymerizing Factors (Cofilins)IBA 04/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	AlbuminsIBA 01/2022
1	LigandsIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	CalreticulinIBA 11/2021
1	CateninsIBA 11/2021
1	Aldehyde DehydrogenaseIBA 11/2021
1	CalciumIBA 11/2021
1	NeuropeptidesIBA 01/2021
1	NeurotensinIBA 01/2021
1	Estrogen ReceptorsIBA 08/2019
1	Small Interfering RNA (siRNA)IBA 08/2019
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 10/2018
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2016
1	MicroRNAs (MicroRNA)IBA 06/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2015
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2015
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 09/2015
1	Lubricant Eye Drops (Artificial Tears)IBA 01/2015
1	Trans-Activators (Trans-Acting Factor)IBA 06/2013
1	Cocaine (Cocaine HCl)IBA 10/2011
1	Fluorouracil (Carac)FDA LinkGeneric 09/2008

Therapy/Procedure

5	Therapeutics 11/2023 - 09/2016
5	Electroacupuncture 01/2022 - 01/2016
3	Acupuncture Therapy 01/2024 - 01/2015
3	Radiotherapy 01/2023 - 09/2013
3	Drug Therapy (Chemotherapy) 11/2019 - 09/2008
2	Immunotherapy 01/2021 - 03/2014
1	Photochemotherapy (Photodynamic Therapy) 10/2023
1	Anesthesia 12/2022
1	Stents 08/2022
1	Prostatectomy (Retropubic Prostatectomy) 01/2022
1	Aftercare (After-Treatment) 01/2018
1	Conservative Treatment 01/2016
1	Induced Hyperthermia (Thermotherapy) 03/2014
1	Biological Therapy 03/2014